InflaRx
Price & Volume
Stats
See more52W Range | $0.82-$2.81 |
Market Cap | $83.1M |
Shares Short | 924,154 |
Financials
See moreRevenue (12 Mos) | $165,789 |
Revenue Growth (YoY) | 103.6% |
Gross Profit (12 Mos) | -$3.1M |
Diluted EPS | -$0.88 |
News
See moreYahoo Finance • last month
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
Yahoo Finance • 2 months ago
InflaRx to Report Full Year 2024 Results on March 20 and Announces Participation in March Investor Conferences
Yahoo Finance • 2 months ago
InflaRx Announces Closing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Yahoo Finance • 2 months ago
InflaRx Announces Pricing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
About
CEO | Dr. Niels C. Riedemann M.D., Ph.D. |
Address | Winzerlaer Str. 2, Jena, Germany, 07745 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 74 |
